Want to see IN:PFIZER full AI Analyst Report?
PFIZER Stock Chart & Stats
₹4887.30
₹34.05(0.64%)
At close: 4:00 PM EST
₹4887.30
₹34.05(0.64%)
Day’s Range― - ―
52-Week Range₹4,361.00 - ₹5,890.00
Previous CloseN/A
Volume78.28K
Average Volume (3M)2.39K
Market Cap
₹204.83B
Enterprise Value₹175.16B
Total Cash (Recent Filing)₹27.06B
Total Debt (Recent Filing)₹898.30M
Price to Earnings (P/E)28.3
Beta0.57
Next Earnings
Aug 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.69%
Share Statistics
EPS (TTM)183.46
Shares Outstanding45,747,730
10 Day Avg. Volume3,328
30 Day Avg. Volume2,388
Financial Highlights & Ratios
PEG Ratio-5.08
Price to Book (P/B)5.14
Price to Sales (P/S)8.57
P/FCF Ratio19.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)182.03
Revenue Forecast (FY)₹27.44B
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetExceptionally low debt-to-equity (well below 0.10) provides durable financial resilience, enabling sustained R&D investment, stable supplier relationships, and flexible capital allocation. This structural strength reduces refinancing risk and supports operations through industry cycles.
Sustained High ProfitabilityMid-20% to mid-30% net margins indicate durable pricing power and operating efficiency across therapeutic franchises. Sustained high margins underpin cash generation, fund innovation, and allow competitive commercial spend without eroding core profitability over the medium term.
Improved Cash GenerationRecent step-up in operating and free cash flow, where OCF exceeds net income and FCF approximates earnings, signals improved earnings quality and stronger cash conversion. That enhances capacity to fund capex, R&D, or shareholder returns without adding leverage.
Bears Say
Uneven Revenue TrendsChoppy top-line performance across multiple years indicates demand or portfolio volatility and complicates forecasting. Persistent uneven revenue undermines planning for manufacturing, marketing scale, and R&D prioritization, increasing execution risk over the medium term.
Gross-Margin Pressure In 2026A meaningful gross-margin decline in 2026 could reflect cost inflation, adverse product-mix, or pricing pressure. If structural, margin deterioration would erode the company’s strong operating leverage and reduce free cash flow available for reinvestment and returns.
Cash-Flow VolatilityMulti-year variability in operating cash conversion raises concerns about sustainability of cash-driven initiatives. Volatile OCF versus earnings can constrain predictable funding for pipelines, dividends or buybacks and increases sensitivity to working-capital swings.
PFIZER LIMITED News
PFIZER FAQ
What was PFIZER LIMITED’s price range in the past 12 months?
PFIZER LIMITED lowest stock price was ₹4361.00 and its highest was ₹5890.00 in the past 12 months.
What is PFIZER LIMITED’s market cap?
PFIZER LIMITED’s market cap is ₹204.83B.
When is PFIZER LIMITED’s upcoming earnings report date?
PFIZER LIMITED’s upcoming earnings report date is Aug 03, 2026 which is in 32 days.
How were PFIZER LIMITED’s earnings last quarter?
PFIZER LIMITED released its earnings results on May 12, 2026. The company reported ₹42.2 earnings per share for the quarter, beating the consensus estimate of ₹40.25 by ₹1.95.
Is PFIZER LIMITED overvalued?
According to Wall Street analysts PFIZER LIMITED’s price is currently Overvalued.
Does PFIZER LIMITED pay dividends?
PFIZER LIMITED pays a Notavailable dividend of ₹75 which represents an annual dividend yield of 0.69%. See more information on PFIZER LIMITED dividends here
What is PFIZER LIMITED’s EPS estimate?
PFIZER LIMITED’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PFIZER LIMITED have?
PFIZER LIMITED has 45,747,730 shares outstanding.
What happened to PFIZER LIMITED’s price movement after its last earnings report?
PFIZER LIMITED reported an EPS of ₹42.2 in its last earnings report, beating expectations of ₹40.25. Following the earnings report the stock price went down -3.036%.
Which hedge fund is a major shareholder of PFIZER LIMITED?
Currently, no hedge funds are holding shares in IN:PFIZER
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PFIZER LIMITED
Pfizer Limited operates as a pharmaceutical company, engaged in the development, promotion, sale, and international export of medicinal products. Its diverse product range addresses numerous therapeutic needs, such as those related to the neuro/central nervous system, hormonal balance, cardiovascular health, hemophilia, infectious diseases, gynecology, pain relief, orthopedic conditions, oncology, urology, parasitic infections, gastrointestinal disorders, vaccinations, respiratory ailments, and nutritional supplements. The company markets its offerings predominantly under various brand names through an extensive network of independent distributors. Established in 1950, its corporate headquarters are situated in Mumbai, India.
Technical Analysis
Abbott India Limited
―
Cipla Ltd
―
Gland Pharma Ltd.
―
GlaxoSmithKline Pharmaceuticals Limited
―
Sanofi India Limited
―